120 related articles for article (PubMed ID: 8019773)
1. Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.
Derrien M; Durieux C; Roques BP
Br J Pharmacol; 1994 Mar; 111(3):956-60. PubMed ID: 8019773
[TBL] [Abstract][Full Text] [Related]
2. Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Smadja C; Maldonado R; Turcaud S; Fournie-Zaluski MC; Roques BP
Psychopharmacology (Berl); 1995 Aug; 120(4):400-8. PubMed ID: 8539320
[TBL] [Abstract][Full Text] [Related]
3. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
[TBL] [Abstract][Full Text] [Related]
5. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
Dauge V; Corringer PJ; Roques BP
Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
[TBL] [Abstract][Full Text] [Related]
6. CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration.
Durieux C; Derrien M; Maldonado R; Valverde O; Blommaert A; Fournié-Zaluski MC; Roques BP
Ann N Y Acad Sci; 1994 Mar; 713():355-7. PubMed ID: 8185186
[No Abstract] [Full Text] [Related]
7. CCKB receptor activation results in increased [3H]thymidine incorporation in rat glioma C6 cells.
Kaufmann R; Henklein P; Nowak G
Neuropeptides; 1995 Nov; 29(5):241-4. PubMed ID: 8587658
[TBL] [Abstract][Full Text] [Related]
8. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
Derrien M; Noble F; Maldonado R; Roques BP
Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of CCK-B receptors involved in animal models of anxiety.
Derrien M; McCort-Tranchepain I; Ducos B; Roques BP; Durieux C
Pharmacol Biochem Behav; 1994 Sep; 49(1):133-41. PubMed ID: 7816864
[TBL] [Abstract][Full Text] [Related]
12. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
Durieux C; Ruiz-Gayo M; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
Ayres EA; Parkhurst DN; Fang S; Kramer TH; Hruby VJ; Burks TF
Proc West Pharmacol Soc; 1991; 34():477-84. PubMed ID: 1788334
[No Abstract] [Full Text] [Related]
14. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
15. Ceruletide suppresses rotational behavior in lesioned rats via CCKA receptors.
Fujisawa M; Miyamoto O; Itano T; Tokuda M; Matsui H; Nagao S; Negi T; Hatase O
Eur J Pharmacol; 1993 Jul; 238(1):127-30. PubMed ID: 8405076
[TBL] [Abstract][Full Text] [Related]
16. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat.
Daugé V; Samir A; Cupo A; Roques BP
Neuropharmacology; 1999 Jul; 38(7):999-1007. PubMed ID: 10428418
[TBL] [Abstract][Full Text] [Related]
17. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
[TBL] [Abstract][Full Text] [Related]
18. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus.
Corsi M; Pojani G; Dal Forno G; Pietra C; Gaviraghi G; Trist D
Br J Pharmacol; 1993 Apr; 108(4):1164-8. PubMed ID: 8485626
[TBL] [Abstract][Full Text] [Related]
20. The CCKB antagonist, L-365,260, attenuates fear-potentiated startle.
Josselyn SA; Frankland PW; Petrisano S; Bush DE; Yeomans JS; Vaccarino FJ
Peptides; 1995; 16(7):1313-5. PubMed ID: 8545257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]